SBTX — Skinbiotherapeutics Share News
0.000.00%
- £60.81m
- £60.60m
- £1.21m
REG - SkinBioTherapeutics - Conversion Notice and Total Voting Rights
AnnouncementREG - SkinBioTherapeutics - AxisBiotix Acne study reports positive data
AnnouncementREG - AIM - AIM Notice - 30/05/2024
AnnouncementREG - SkinBioTherapeutics - Conversion Notice and Total Voting Rights
AnnouncementREG - SkinBioTherapeutics - Holding(s) in Company
AnnouncementREG - SkinBioTherapeutics - Conversion Notice & Total Voting Rights
AnnouncementREG - SkinBioTherapeutics - Half-year Report
AnnouncementREG - SkinBioTherapeutics OptiBiotix Health - Holding(s) in Company
AnnouncementREG - SkinBioTherapeutics - New research project and CSO to return to academia
AnnouncementREG - SkinBioTherapeutics - Conversion Notice and Total Voting Rights
AnnouncementREG - SkinBioTherapeutics - Notice of Results
AnnouncementREG - AIM - AIM Notice - 29/02/2024
AnnouncementREG - SkinBioTherapeutics - Conversion notice and alternative financing
AnnouncementREG - SkinBioTherapeutics - Positive Interim AxisBiotix Acne study results
AnnouncementREG - SkinBioTherapeutics - Dermatonics to launch Once Heel Balm in AMEA
AnnouncementREG - SkinBioTherapeutics - Conversion Notice and Total Voting Rights
AnnouncementREG - SkinBioTherapeutics - Dermatonics Full Year trading update
AnnouncementREG - SkinBioTherapeutics - Completion of Acquisition of Dermatonics
AnnouncementREG - SkinBioTherapeutics - £5.0m Convertible Bond Facility & First Drawdown
Announcement